SURE — Surenano Science Balance Sheet
0.000.00%
Last trade - 00:00- CA$1.18m
- CA$1.05m
Annual balance sheet for Surenano Science, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.929 | 0.667 | 0.277 | 0.135 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.038 | 0.017 | 0.021 | 0.003 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.967 | 0.686 | 0.309 | 0.147 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | — | 0.008 | 0.006 |
| Total Assets | 0.967 | 0.686 | 0.318 | 0.153 |
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.017 | 0.036 | 0.058 | 0.173 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.017 | 0.036 | 0.058 | 0.173 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 0.949 | 0.65 | 0.26 | -0.02 |
| Total Liabilities & Shareholders' Equity | 0.967 | 0.686 | 0.318 | 0.153 |
| Total Common Shares Outstanding |